FDA Clears New 1.5T MRI Coil
InkSpace Imaging’s 24-channel MRI coil, which will be included in Magnetom 1.5T scanners from Siemens Healthineers, reportedly facilitates quicker set-ups for technologists and enhanced spatial resolution.
The Food and Drug Administration (FDA) has granted 510(k) clearance for a 1.5T, 24-channel magnetic resonance imaging (MRI) coil, which reportedly enables improvements in workflow efficiency, image quality and patient comfort.
InkSpace Imaging, the developer of the new MRI coil, said high-density coil elements enhance spatial resolution and parallel imaging compatibility helps reduce artifacts while facilitating scan time reductions.
In addition to streamlining scan set-ups for technologists, the newly FDA-cleared 1.5T, 24-channel MRI coil bolsters spatial resolution and helps reduce artifacts, according to InkSpace Imaging, the developer of the new MRI coil. (Photo courtesy of InkSpace Imaging.)
The 1.5T MRI coil, which will be included in Magnetom MRI scanners from Siemens Healthineers, also streamlines scan set-ups for technologists, according to InkSpace Imaging. The company added that the ultra-lightweight coil conforms to patient anatomy, ensuring comfort for diverse body types.
“The 1.5T MR coil sets a new benchmark for image quality and operational efficiency, empowering radiologists to achieve better patient outcomes,” added Peter Fischer, the CEO of InkSpace Imaging.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
